Gross cannabis revenue rose 16% year-over-year to CAD 44.1 million, with net income at CAD 4.8 million and adjusted EBITDA up 11% to CAD 8.5 million. Market share gains in Ontario and Alberta, strategic acquisitions, and a CAD 21 million Curaleaf deal support accelerated capacity expansion and international growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.